2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease
- 1 July 1988
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 85 (3) , 309-317
- https://doi.org/10.1016/0022-510x(88)90189-x
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Persistent depletion of striatal dopamine and its metabolites in mice by TMMP, an analogue of MPTPJournal of Pharmacy and Pharmacology, 1987
- V. 4-phenylpyridine (4PP) and MPTP: The relationship between striatal MPP+ concentrations and neurotoxicityLife Sciences, 1987
- I. The development of amine substituted analogues of MPTP as unique tools for the study of MPTP toxicity and Parkinson's diseaseLife Sciences, 1987
- Mitochondria and the neurotoxicity of MPTPTrends in Pharmacological Sciences, 1986
- Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patientsNeuroscience Letters, 1986
- Persistent depletion of striatal dopamine in mice by 1-Methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine (MTTP)Biochemical Pharmacology, 1986
- Reduction of Phenyl-Substituted Pyridinium Methoiodides with Sodium Borohydride. Formation of Amine-Borane Complexes in WaterSynthetic Communications, 1985
- MPTP and parkinson's diseaseTrends in Neurosciences, 1985
- Effects of N-substituted phenyltetrahydropyridines on cerebral high-affinity synaptosomal uptake of dopamine and other monoamines in several mammalian speciesLife Sciences, 1984
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983